Classification of patient-specific sensitivity to immunotherapies by ex vivo tumor testing

被引：0
|
作者：
Ceton, Lieke Johanna
Montero, Marta Garcia
Grillet, Fanny
van der Meer, Dieudonne J.
Vader, Willemijn
van Altena, Anne
de Kroon, Cor D.
Ottevanger, Nelleke
Kroep, Judith
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4113
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A patient-specific in vivo tumor model
    Wasserman, R
    Acharya, R
    Sibata, C
    Shin, KH
    MATHEMATICAL BIOSCIENCES, 1996, 136 (02) : 111 - 140
  • [2] Engineering patient-specific cancer immunotherapies
    Scheetz, Lindsay
    Park, Kyung Soo
    Li, Qiao
    Lowenstein, Pedro R.
    Castro, Maria G.
    Schwendeman, Anna
    Moon, James J.
    NATURE BIOMEDICAL ENGINEERING, 2019, 3 (10) : 768 - 782
  • [3] Identification of patient specific immune therapy treatment sensitivity by ex vivo testing
    Grillet, F.
    de Kroon, C.
    Kroep, J. R.
    Overkamp, J.
    Jariani, A.
    Daszkiewicz, L.
    Yan, K.
    van der Meer, D.
    Price, L.
    Vader, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S788 - S788
  • [4] Engineering patient-specific cancer immunotherapies
    Lindsay Scheetz
    Kyung Soo Park
    Qiao Li
    Pedro R. Lowenstein
    Maria G. Castro
    Anna Schwendeman
    James J. Moon
    Nature Biomedical Engineering, 2019, 3 : 768 - 782
  • [5] Interpretation of patient-specific ex vivo immunotherapy response for ovarian cancer
    Ceton, Lieke
    Koedoot, Esmee
    Sijsenaar, Timothy
    Garcia, Marta Montero
    Grillet, Fanny
    van der Valk, Jurrian
    Weber, Klaus
    Schoenauer, Roman
    Hufnagel, Katrin
    Schmidt, Ronny
    Stroh, Nadine
    Boekhoff, Henning
    de Kroon, Cor
    van Altena, Anne
    van der Meer, Dieudonne
    Vader, Willemijn
    Ottevanger, Nelleke
    Kroep, Judith
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] Ex Vivo Patient-Specific Validation Of Personalized Therapeutic Designed For Multiple Myeloma
    Doudican, Nicole A.
    Vali, Shireen
    Kapoor, Shweta
    Talawdekar, Anay
    Sultana, Zeba
    Alam, Aftab
    Kumar, Ansu
    Singh, Neeraj Kumar
    Tyagi, Anuj
    Abbasi, Taher
    Mazumder, Amitabha
    BLOOD, 2013, 122 (21)
  • [7] Ex vivo basket study reports patient-specific sensitivity to carboplatin versus cisplatin in lung, ovarian and bladder cancer
    Robbrecht, D.
    Koedoot, E.
    van der Meer, D.
    Ceton, L. J.
    Sijsenaar, T.
    Vader, W.
    Steinbusch, L.
    Steendam, C.
    Boormans, J.
    Ottevanger, P. B.
    ANNALS OF ONCOLOGY, 2024, 35 : S771 - S771
  • [8] Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo S.
    Vader, Willemijn
    CANCER RESEARCH, 2020, 80 (16)
  • [9] ENGINEERING AN EX-VIVO PERFUSION-BASED BIOREACTOR SYSTEM FOR DRUG-TESTING ON PATIENT-SPECIFIC CANCER SPECIMENS
    Muraro, Manuele Giuseppe
    Mazzoleni, Andrea
    Kabak, Evrim Ceren
    Scherberich, Arnaud
    Martin, Ivan
    TISSUE ENGINEERING PART A, 2022, 28 : S288 - S288
  • [10] A Patient-Specific Ex Vivo Screening Platform for Personalized Acute Myeloid Leukemia (AML) Therapy
    Azzam, Diana
    Volmar, Claude-Henry
    Hassan, Al-Ali
    Perez, Aymee
    Watts, Justin M.
    Vargas, Fernando
    Elias, Roy
    Vega, Francisco
    Zelent, Arthur
    Cogle, Christopher R.
    Wahlestedt, Claes
    Swords, Ronan T.
    BLOOD, 2015, 126 (23)
12345